Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.32 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | CASP1 | P29466 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9284397 | 0.83 | CA2 (0.58) | CA2ALDH1A1NPSR1CHRM2CHRM4 | |
| SCHEMBL619199 | 0.83 | CA2 (0.58) | CA2ALDH1A1NPSR1CHRM2CHRM4 | |
| SCHEMBL8182426 | 0.83 | CA2 (0.58) | CA2ALDH1A1NPSR1CHRM2CHRM4 | |
| SCHEMBL7875753 | 0.81 | CA2 (0.59) | CA2ALDH1A1NPSR1CHRM2CHRM4 | |
| SCHEMBL619198 | 0.78 | CA2 (0.56) | CA2ALDH1A1NPSR1CHRM2CHRM4 | |
| SCHEMBL220562 | 0.78 | CA2 (0.61) | CA2ALDH1A1NPSR1CHRM2CHRM4 | |
| SCHEMBL220561 | 0.78 | CA2 (0.61) | CA2ALDH1A1NPSR1CHRM2CHRM4 | |
| SCHEMBL10471474 | 0.78 | CA2 (0.56) | CA2ALDH1A1NPSR1CHRM2CHRM4 | |
| SCHEMBL14533189 | 0.78 | CA2 (0.56) | CA2ALDH1A1NPSR1CHRM2CHRM4 | |
| SCHEMBL220873 | 0.78 | CA2 (0.61) | CA2ALDH1A1NPSR1CHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8309733-B2 | Imino derivatives, methods for producing the same and insecticides containing the same | Meji Seika Pharma Co., Ltd. (JP) | 2012-11-13 | — | — | US | disclosed |
| US-20110172433-A1 | NOVEL IMINO DERIVATIVES, METHODS FOR PRODUCING THE SAME AND INSECTICIDES CONTAINING THE SAME | MEIJI SEIKA KAISHA, LTD. (JP) | 2011-07-14 | — | — | US | disclosed |
| US-20100222218-A1 | INSECTICIDAL HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2010-09-02 | — | — | US | disclosed |
| US-20070105890-A1 | Novel condensed imidazole derivative | DAINIPPON SUMITOMO PHARMA CO., LTD | 2007-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070105890-A1 | Novel condensed imidazole derivative | DPP4, DPP7, DPP3 | CA2 1527/4885ALDH1A1 63/4885NPSR1 1770/4885 |
| US-20100222218-A1 | INSECTICIDAL HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES | DDT, CYCS, DDC | CA2 161/4885ALDH1A1 214/4885NPSR1 2867/4885 |
| US-20110172433-A1 | NOVEL IMINO DERIVATIVES, METHODS FOR PRODUCING THE SAME AND INSECTICIDES CONTAINING THE SAME | CNOT9, CBR1, CBR3 | CA2 1302/4885ALDH1A1 1181/4885NPSR1 925/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.